We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
+71.98%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$42.4B
AUM Growth
+$14.2B
(+50%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
284
New
32
Increased
89
Reduced
83
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$416M |
| 2 |
Palo Alto Networks
PANW
|
+$383M |
| 3 |
CrowdStrike
CRWD
|
+$306M |
| 4 |
AstraZeneca
AZN
|
+$235M |
| 5 |
Silicon Motion
SIMO
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$548M |
| 2 |
Ciena
CIEN
|
+$310M |
| 3 |
Broadcom
AVGO
|
+$297M |
| 4 |
Lumentum
LITE
|
+$294M |
| 5 |
Advanced Micro Devices
AMD
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.75% |
| 2 | Miscellaneous | 16.86% |
| 3 | Healthcare | 13.2% |
| 4 | Financials | 8.03% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Berkshire Hathaway Class B
BRK.B
$1.1T
| $49M | 0.12% |
97,908
-2,802
| -3% | -$1.35M |
|
127
Roivant Sciences
ROIV
$28.8B
| $48.7M | 0.12% |
1,376,554
-201,754
| -13% | -$5.96M |
|
128
Tango Therapeutics
TNGX
$3.99B
| $46.3M | 0.11% |
+1,480,740
| New | +$36.6M |
|
129
SiTime
SITM
$16.6B
| $45.8M | 0.11% |
61,388
+2,546
| +4% | +$1.61M |
|
130
Pinduoduo
PDD
$111B
| $45.2M | 0.11% |
592,084
-10,921
| -2% | -$1.01M |
|
|
BOW
131
Bowhead Specialty Holdings
BOW
$1.11B
| $44.9M | 0.11% |
1,500,000
| – | – |
|
132
Halliburton
HAL
$29.3B
| $44.3M | 0.1% |
+1,303,572
| New | +$50.9M |
|
133
CVS Health
CVS
$121B
| $43.6M | 0.1% |
421,822
-65,784
| -13% | -$5.87M |
|
134
Trupanion
TRUP
$1.16B
| $43.3M | 0.1% |
1,750,000
+125,000
| +8% | +$3.04M |
|
135
Thermo Fisher Scientific
TMO
$234B
| $43M | 0.1% |
85,677
+9,697
| +13% | +$4.66M |
|
136
Dell
DELL
$351B
| $41.8M | 0.1% |
+96,780
| New | +$28M |
|
|
JBIO
137
Jade Biosciences
JBIO
$1.11B
| $41M | 0.1% |
+1,846,982
| New | +$38.5M |
|
138
Datadog
DDOG
$81.7B
| $41M | 0.1% |
+157,298
| New | +$29.2M |
|
139
RadNet
RDNT
$6.16B
| $38.4M | 0.09% |
623,029
-111,224
| -15% | -$6.25M |
|
140
Mineralys Therapeutics
MLYS
$2.44B
| $38.3M | 0.09% |
1,420,854
-79,895
| -5% | -$2.19M |
|
|
AXON
141
Axon Enterprise
AXON
$35.5B
| $37.5M | 0.09% |
66,971
+42,942
| +179% | +$18M |
|
|
DFTX
142
Definium Therapeutics
DFTX
$5.06B
| $36.6M | 0.09% |
+777,253
| New | +$19.2M |
|
143
Tesla
TSLA
$1.41T
| $36.4M | 0.09% |
86,537
-170,964
| -66% | -$68M |
|
144
JPMorgan Chase
JPM
$922B
| $35.1M | 0.08% |
107,219
-6,055
| -5% | -$1.88M |
|
145
Trip.com Group
TCOM
$24.8B
| $35M | 0.08% |
878,264
-113,142
| -11% | -$5.61M |
|
146
Taysha Gene Therapies
TSHA
$1.63B
| $34.8M | 0.08% |
5,117,133
-537,207
| -10% | -$3.18M |
|
147
Relay Therapeutics
RLAY
$4.1B
| $33.5M | 0.08% |
+1,789,056
| New | +$26M |
|
148
Affirm
AFRM
$24.2B
| $33M | 0.08% |
404,896
+26,212
| +7% | +$1.71M |
|
149
Centene
CNC
$33.4B
| $30.3M | 0.07% |
471,635
-274,702
| -37% | -$14.7M |
|
150
Aflac
AFL
$58.5B
| $29.3M | 0.07% |
250,000
-125,000
| -33% | -$14.4M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2026 Portfolio in Review
As of Q2 2026, Polar Capital Holdings held 284 positions worth $42.4B, up 50% from $28.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Polar Capital Holdings deployed $1.31B of net new capital in Q2 2026, opening 32 new positions and adding to 89 existing holdings. Its largest new stake was Palo Alto Networks: 1,672,688 shares worth $570M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 42% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Sandisk, an estimated $548M trimmed.
- Polar Capital Holdings's largest Q2 2026 buy was Palo Alto Networks: 1,672,688 shares worth $570M.
- Polar Capital Holdings added most to NVIDIA in Q2 2026, an estimated $416M increase.
- Polar Capital Holdings's biggest Q2 2026 reduction was Sandisk, cutting an estimated $548M.
- Polar Capital Holdings fully exited Ciena in Q2 2026, selling an estimated $310M.
- Polar Capital Holdings's ten largest holdings make up 40% of its $42.4B portfolio in Q2 2026.
- Polar Capital Holdings opened 32 new positions and closed 47 in Q2 2026.
- Polar Capital Holdings's portfolio value rose 50% quarter-over-quarter to $42.4B.
Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.